SUPPORTING INDIVIDUALS, FAMILIES AND RESEARCHERS
IN THE CYSTINOSIS COMMUNITY

Further Funding for Sunderland Prodrug Development

We are pleased to announce that we have extended the funding to University of Sunderland to continue their work on Developing a Prodrug for the treatment of Cystinosis. This £75,000.00 of funding will support the pre-clinical work that is necessary to progress to pre-clinical trials and to further develop an ocular prodrug treatment. The project will run from February next year for around 14 months.

The work to date on developing suitable compounds for a Prodrug have progressed as expected with a strong candidate having been identified. Sunderland University continue to work on this with wider partners in the Cystinosis research community.

Comments are closed.

Novartis Gene Therapy Update We have received this message from Novartis regarding their gene therapy program for [...] Read more...
CNE International Conference 2024 Cystinosis Network Europe and Cystinosis Foundation UK are delighted to announce the 2024 [...] Read more...
Cystinosis Comic Book Series by Artist Kevin McCalla The Cystinosis Research Network in the US has teamed up with Kevin McCalla, a young artist who [...] Read more...
Summer 2023 Newsletter The Summer 2023 edition of our email newsletter is available to view at the link below. CFUK [...] Read more...
All website content copyright Cystinosis Foundation UK (Charity No.1074885) 1997-2013, except where explicitly stated.
Data Protection Act Registration Number: Z9880997. Please refer to our terms and conditions and our privacy policy.
site:bonnyday